What are the differences between Type 1 (hypoxemic) and Type 2 (hypercapnic) respiratory failure based on arterial blood gas (ABG) analysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type 1 and Type 2 Respiratory Failure Based on ABG

Type 1 respiratory failure is defined by PaO₂ <8 kPa (60 mmHg) with normal or low PaCO₂, while Type 2 respiratory failure is defined by PaO₂ <8 kPa AND PaCO₂ >6.0 kPa (45 mmHg). 1

ABG Criteria for Classification

Type 1 (Hypoxemic) Respiratory Failure

  • PaO₂ <8 kPa (60 mmHg) - equivalent to SpO₂ approximately 90% 1
  • PaCO₂ normal (4.6-6.1 kPa) or low 1
  • Results from failure of oxygenation despite adequate ventilation 1

Type 2 (Hypercapnic) Respiratory Failure

  • PaO₂ <8 kPa (60 mmHg) 1
  • PaCO₂ >6.0 kPa (45 mmHg) - this is the critical distinguishing feature 1
  • Often accompanied by respiratory acidosis (pH <7.35) when acute 1

Important threshold clarification: The BTS/ICS guidelines specify that NIV should be considered when PaCO₂ is between 6.0-6.5 kPa, but NIV should be started when PaCO₂ ≥6.5 kPa with pH <7.35 after optimal medical therapy. 1

Key Distinguishing Features on ABG

Acute vs. Chronic Type 2 Failure

  • Acute hypercapnic respiratory failure: pH <7.35 with elevated PaCO₂, indicating insufficient renal compensation 1
  • Chronic compensated: Normal or near-normal pH despite elevated PaCO₂, due to renal bicarbonate retention over hours to days 1
  • Acute-on-chronic: Elevated PaCO₂ with pH <7.35 despite baseline bicarbonate elevation 1

Critical pH Thresholds

  • pH <7.35 (H⁺ >45 nmol/L) defines respiratory acidosis and triggers consideration for NIV 1
  • pH <7.25 indicates severe acidosis with higher mortality risk 2
  • Arterial hydrogen ion concentration is a more important prognostic factor than the degree of hypoxemia or hypercapnia alone 2

Common Pitfalls in ABG Interpretation

Oxygen Therapy Confounding

  • Measuring PaO₂ after oxygen administration can mask the diagnosis of respiratory failure - use PaO₂/FiO₂ ratio instead when patients are already on supplemental oxygen 3
  • In one study, using PaO₂/FiO₂ ratio identified an additional 16 cases of respiratory failure that would have been missed using PaO₂ alone 3

Mixed Type 1 and Type 2 Failure

  • Both types can coexist - using PaCO₂ alone to classify can be misleading 3
  • Calculate the alveolar-arterial (A-a) gradient to determine if hypercapnia is due to hypoventilation (Type 2) or V/Q mismatch (Type 1 with secondary hypercapnia) 3
  • In one study, 22 of 57 cases initially classified as Type 2 using PaCO₂ alone were reclassified as Type 1 when A-a gradient was calculated, changing management in 18 cases 3

Practical ABG Interpretation Algorithm

  1. First, assess oxygenation:

    • If on room air: PaO₂ <8 kPa indicates respiratory failure 1
    • If on supplemental oxygen: Calculate PaO₂/FiO₂ ratio (normal >400 mmHg or >53 kPa) 3
  2. Second, assess ventilation:

    • PaCO₂ >6.0 kPa suggests Type 2 component 1
    • PaCO₂ ≥6.5 kPa with pH <7.35 mandates urgent intervention 1
  3. Third, assess acuity:

    • pH <7.35 indicates acute or acute-on-chronic failure requiring immediate treatment 1
    • Normal pH with elevated PaCO₂ suggests chronic compensated failure 1
  4. Fourth, calculate A-a gradient if both hypoxemia and hypercapnia present:

    • Normal A-a gradient with hypercapnia = pure hypoventilation (Type 2) 3
    • Elevated A-a gradient with hypercapnia = V/Q mismatch (Type 1) with secondary hypoventilation 3

Management Implications Based on ABG

Type 1 Failure

  • Target SpO₂ 94-98% in most patients 1
  • High-flow nasal oxygen may reduce intubation rates 4
  • Does not typically respond to NIV unless specific indications present 4

Type 2 Failure

  • Target SpO₂ 88-92% to avoid worsening hypercapnia 1, 4
  • Repeat ABG after 1 hour of optimal medical therapy to determine if NIV is needed 1
  • Start NIV when pH <7.35 and PaCO₂ ≥6.5 kPa persist after initial treatment 1
  • Repeat ABG 1-2 hours after starting NIV, then again at 4-6 hours to assess response 1, 4

Critical Warning

Never administer high-flow oxygen to patients with suspected Type 2 failure without ABG confirmation and close monitoring - this can precipitate CO₂ narcosis and respiratory arrest. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

SMART phones and the acute respiratory patient.

Irish medical journal, 2012

Guideline

Respiratory Failure Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.